Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses treatment therapies and…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his website OncTalk,…
When a child is diagnosed with cancer, everyone in the family needs healing… including the siblings! SuperSibs! is a national not-for-profit whose mission is to ensure that the…
A new analysis of data from a multicenter clinical trial suggests that chemotherapy-induced anemia significantly increases the risk of local relapse in premenopausal early-stage breast cancer. References and…
A new study shows that the aromatase inhibitor letrozole can prevent late recurrence of breast cancer. References and Resources Goss P, et al. Late extended adjuvant treatment with…
Statin use at the time of ovarian cancer surgery was associated with a 50% increase in the duration of progression-free survival and with more than a year of…
The Oncologic Drug Advisory Committee said the FDA should mandate a restricted distribution system for cancer patients given erythropoiesis-stimulating agents. References and Resources FDA.gov Sponsored by The Doctor’s…
Results of a Gynecologic Oncology Group study suggest that for patients with recurrent cervical cancer, bevacizumab has demonstrated activity and promise as an option for second or third…
Erythropoiesis-stimulating agent administration to patients with cancer is associated with increased risks of VTE and mortality. References and Resources Bennett C., Silver S., Djulbegovic B., et al. Venous…
The FDA has issued an update to inform the public that Baxter Healthcare Corporation has extended its recall of multi-dose vials of heparin sodium for injection to also…
